Dry weight assessment by combined ultrasound and bioimpedance monitoring in low cardiovascular risk hemodialysis patients: a randomized controlled trial
ConclusionsThis study shows that a LUS –bioimpedance-guided dry weight adjustment protocol, as compared to clinical evaluation, does not reduce all-cause mortality and/or CVE in HD patients. A fluid management protocol based on bioimpedance with LUS on indication might be a better strategy.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Dialysis | Heart | Heart Attack | Hemodialysis | Stroke | Study | Ultrasound | Urology & Nephrology